phosphatidylcholines has been researched along with Cryptococcosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baddour, LM; Ostrosky-Zeichner, L; Perfect, JR | 1 |
| Khan, MA; Nasti, TH; Owais, M | 1 |
| Chandrasekar, P | 1 |
| Calza, L; Manfredi, R | 1 |
| Altintas, ND; Arikan, S; Burnik, C; Cuenca-Estrella, M; Firat, P; Ozkaya, G; Selçuk, ZT; Serter, T; Topeli, A | 1 |
| Brajtburg, J; Elberg, S; Kobayashi, GS; Travis, SJ | 1 |
| Anaissie, EJ; Bow, E; DiNubile, MJ; Hiemenz, JW; Horwith, G; Lee, L; Lister, J; Perfect, JR; Reboli, A; Seibel, NL; Silber, JL; Walsh, TJ | 1 |
1 review(s) available for phosphatidylcholines and Cryptococcosis
| Article | Year |
|---|---|
Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Biopsy; Cryptococcosis; Cryptococcus; Drug Combinations; Humans; Lung; Male; Phosphatidylcholines; Phosphatidylglycerols; Pneumonia; Respiratory Distress Syndrome | 2007 |
1 trial(s) available for phosphatidylcholines and Cryptococcosis
| Article | Year |
|---|---|
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Cryptococcosis; Drug Combinations; Female; Humans; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
5 other study(ies) available for phosphatidylcholines and Cryptococcosis
| Article | Year |
|---|---|
Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Combinations; Female; Humans; Immunocompromised Host; Male; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome | 2005 |
Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model.
Topics: Animals; Antifungal Agents; Brain; Cryptococcosis; Drug Carriers; Hydrogen-Ion Concentration; Intercalating Agents; Liposomes; Liver; Male; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Survival Analysis | 2006 |
The experience is CLEAR.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis | 2006 |
Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis; Cryptococcosis; Drug Combinations; Fungemia; Humans; Phosphatidylcholines; Phosphatidylglycerols; Viscera | 2007 |
Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
Topics: Amphotericin B; Animals; Bile Acids and Salts; Candidiasis; Cryptococcosis; Dose-Response Relationship, Drug; Drug Carriers; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred Strains; Micelles; Phosphatidylcholines | 1994 |